Welcome to our dedicated page for CNA Financial SEC filings (Ticker: CNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CNA Financial Corporation (NYSE: CNA) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed information on CNA’s commercial property and casualty insurance operations, non-core segments and capital structure.
Investors can review Form 8-K filings that report material events such as quarterly results announcements, leadership changes, underwriting agreements for senior unsecured notes and the closing of note offerings. For example, CNA has furnished press releases, financial supplements, earnings presentations and earnings remarks related to its second and third quarter 2025 results via Form 8-K, and has reported the entry into and closing of an underwriting agreement for notes due 2035.
Filings also document governance developments, including changes in executive roles, board composition and executive separation agreements. These disclosures provide insight into CNA’s leadership structure and compensation-related arrangements for certain officers.
Through its registration statements and prospectus supplements, CNA details the terms of senior unsecured notes issued under its shelf registration. Related exhibits in 8-K filings include underwriting agreements, forms of notes and legal opinions regarding the legality of the securities.
On Stock Titan, CNA’s SEC filings are updated in line with EDGAR, and AI-powered tools can assist users in understanding the content and implications of lengthy documents. Summaries can highlight key items such as reported net income and core income, property and casualty combined ratios, catastrophe losses, reserve development, capital markets transactions and governance events disclosed in the filings.
Users interested in CNA’s insurance performance, capital management and corporate governance can use this page to locate relevant 8-Ks, registration statements and related exhibits, and rely on AI-generated insights to navigate complex regulatory language.
CNA Financial Corp insider plans additional stock sale under Rule 144. A holder intends to sell 6,250 shares of CNA common stock through Fidelity Brokerage Services on or about 12/01/2025 on the NYSE, with an indicated aggregate market value of $293,250.00. CNA had 270,665,399 common shares outstanding for context.
The shares to be sold were acquired on 03/15/2023 through vesting of a performance share plan. Over the prior three months, the same seller completed three separate sales of 6,250 CNA shares each, with gross proceeds of $306,250.00 on 09/02/2025, $289,062.50 on 10/01/2025, and $283,000.00 on 11/03/2025. The seller represents that they are not aware of undisclosed material adverse information about CNA’s current or prospective operations.
CNA Financial (CNA) reported an insider transaction by its SVP & Chief Accounting Officer. On 11/12/2025, the officer reported a Code G transaction, indicating a bona fide gift of 900 shares of common stock at $0.
Following the transaction, the officer reported 21,371 shares beneficially owned, held in direct ownership. The filing was made by a single reporting person and shows no derivative securities activity.
CNA Financial Corporation filed a Form 13F holdings report, listing 12 positions with a Form 13F Information Table value total of $169,764,925.
The report identifies 3 other included managers: Loews Corporation, The Continental Corporation, and Continental Casualty Company. The filing states assets are described as having shared investment discretion among these entities, with each disclaiming ownership except for securities it beneficially owns. As of 9/30/2025, Loews owned approximately 92% of CNA; CNA owned 100% of The Continental Corporation; and The Continental Corporation owned 100% of Continental Casualty Company.
The report was signed by Amy Smith, Senior Vice President and Chief Accounting Officer, in Chicago, IL on 11-14-2025.
CNA Financial (CNA) Executive Chairman and Director Dino E. Robusto reported an open-market sale of 6,250 shares of common stock at $45.28 on November 3, 2025.
The transaction was made under a Rule 10b5-1(c) trading plan adopted on November 15, 2024. After the sale, Robusto beneficially owned 674,338.061 shares, held directly.
CNA Financial (CNA) filed a Form 3 reporting initial beneficial ownership by its SVP & General Counsel. As of 10/29/2025, the reporting person directly owned 8,385 shares of common stock. Table II shows no derivative securities listed. The filing indicates it was submitted by one reporting person.
CNA Financial (CNA) — Form 144 notice of proposed sale. Dino Robusto filed to sell up to 6,250 shares of CNA common stock with an aggregate market value of $283,000. The filing lists Fidelity Brokerage Services as broker and the NYSE as the exchange, with an approximate sale date of 11/03/2025.
The shares were acquired through vesting of PSP on 03/15/2023, in the amount of 6,250. The notice also lists recent sales for the account holder over the past three months: 6,250 shares on 08/04/2025 for $281,250; 6,250 shares on 09/02/2025 for $306,250; and 6,250 shares on 10/01/2025 for $289,062.50. Shares outstanding were 270,665,399. A Form 144 is a notice under Rule 144 and outlines a planned sale by an affiliate.
CNA Financial reported stronger Q3 2025 results as underwriting and investment performance improved. Total revenues were $3,817 million versus $3,618 million a year ago. Net earned premiums rose to $2,783 million, and net investment income was $638 million, while net investment losses were $7 million. Net income increased to $403 million, with diluted EPS of $1.48 compared with $1.04.
Catastrophe losses, net of reinsurance, were $41 million versus $143 million a year ago. Total comprehensive income was $778 million, down from $993 million, reflecting lower other comprehensive income. On the balance sheet, total investments reached $50.5 billion and stockholders’ equity rose to $11,322 million, with accumulated other comprehensive loss improving to $(1,211) million from $(1,991) million.
Year to date, operating cash flow was $1,920 million. The company paid $923 million in dividends and repurchased 700,000 shares for $34 million. Net prior year reserve development was $190 million unfavorable for the nine months, including $134 million in Corporate & Other largely tied to legacy mass tort abuse claim activity.
CNA Financial announced board leadership changes. Dino E. Robusto’s tenure as Executive Chairman and director will end on December 31, 2025, in accordance with his Employment Agreement dated June 5, 2024. The company appointed Douglas M. Worman, its President and Chief Executive, as Chairman of the Board, effective January 1, 2026.
The Board of Directors also approved a reduction in its size to ten, effective January 1, 2026. These updates centralize the CEO and Chairman roles with Mr. Worman and set the board’s composition for the new year.
CNA Financial Corporation filed a current report describing how it shared its third quarter 2025 results. On November 3, 2025, the company issued a press release and posted a financial supplement, earnings presentation and prepared earnings remarks on its website to explain its results of operations for the third quarter of 2025.
These materials are included with the report as exhibits but are designated as “furnished” rather than “filed,” which limits their use under certain securities laws. The filing itself does not repeat the financial figures, instead directing investors to the press release and related documents for detailed quarterly performance information.
Dino E. Robusto, Executive Chairman and Director of CNA Financial Corp (CNA), reported a sale of 6,250 shares of CNA common stock on 10/01/2025 at a price of $46.25 per share. The filing states the sale was executed under a trading plan adopted on 11/15/2024 to satisfy the affirmative defense of Rule 10b5-1(c). After the reported transaction, the amount of common stock beneficially owned is listed as 680,588.061 shares, held directly. The Form 4 was signed by Stathy Darcy by power of attorney for Dino E. Robusto.